Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-23,700
Closed -$1.19M 4072
2014
Q2
$1.19M Hold
23,700
﹤0.01% 2769
2014
Q1
$1.04M Buy
23,700
+9,300
+65% +$442K ﹤0.01% 2985
2013
Q4
$586K Hold
14,400
﹤0.01% 3611
2013
Q3
$484K Buy
+14,400
New +$469K ﹤0.01% 3600

Other funds holding ALKS

David Shaw's ALKS Position: Q2 2026 in Review

David Shaw increased its Alkermes (ALKS) stake by 85% in Q2 2026, buying an estimated $23.5M and bringing the position to 1,312,031 shares worth $68.7M. The position accounts for 0.03% of the portfolio, ranked #604.

David Shaw first reported a position in ALKS in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.3M in Q3 2016. 422 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • David Shaw held 1,312,031 shares of Alkermes worth $68.7M as of Q2 2026.
  • David Shaw bought 601,734 Alkermes shares in Q2 2026, an estimated $23.5M.
  • Alkermes made up 0.03% of David Shaw's portfolio in Q2 2026, its #604 holding.
  • David Shaw first reported a position in Alkermes in Q2 2013 and has held it in 53 quarters since.
  • David Shaw's Alkermes position peaked at $78.3M in Q3 2016.
  • 422 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.